Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

       2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved


      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Active Pharmaceutical Ingredients  TAJ PHARMACEUTICALS LIMITED

Ramipril Manufacturers in India Suppliers Ramipril Exporters Distributors Ramipril api active pharmaceuticals ingredients Ramipril manufacturers Side Effects bulk drugs raw material Ramipril companies Side Effects Importers Ramipril Ramipril Exporters Ramipril exporters FDA Ramipril DMF Symptoms Generic Taj Pharmaceuticals Ltd.

Pharmaceuticals API Manufacturer Ramipril, Ramipril manufacturer India, Ramipril product, Ramipril products, Api preparation, Certificate of Analysis API manufacturer product, Ramipril anti ulcer product, Certificate of Origin COA Ramipril COS Ramipril, pharmaceutical generic, pharmaceutical drug, medical, Ramipril pharma healthcare, pharma patents, contract MSDS manufacturing Trader Ramipril pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Ramipril expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Ramipril DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Ramipril ingredients, api, HIV Ramipril, tablets, capsules, syrup & protein Ramipril powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Ramipril gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Ramipril WHO, UKMHRA Approval

   Pharmaceuticals API List >>
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
red capsules



















HOME >> API >> API List 3 >> Ramipril

Ramiprilis  CAS number 87333-19-5

Ramipril pdf api
CAS number 87333-19-5

Ramipril Formula C23H32N2O5
Systematic (IUPAC) name
(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid

CAS number 87333-19-5
ATC code C09AA05
PubChem 5362129
DrugBank APRD00009
ChemSpider 4514937

Chemical data
Formula C23H32N2O5
Mol. mass 416.511 g/mol
SMILES eMolecules & PubChem

Pharmacokinetic data
Bioavailability 28%
Protein binding 73% (ramipril)
56% (ramiprilat)
Metabolism Hepatic, to ramiprilat
Half life 2 to 4 hours
Excretion Renal (60%) and fecal (40%)

Ramiprilis an angiotensin-converting enzyme (ACE) inhibitor, used to treat hypertension and congestive heart failure. ACE inhibitors lower the production of angiotensin II, therefore relaxing arterial muscles while at the same time enlarging the arteries, allowing the heart to pump blood more easily, and increasing blood flow due to more blood being pumped into and through larger passageways.

Do not take potassium supplements without seeking medical advice.
Do not take during pregnancy

Renovascular disease, severe renal impairment (especially in patients with one kidney or with bilateral renal artery stenosis), volume-depleted patients, history of angioedema while on an ACE inhibitor, pregnancy, hypotension.


  • low blood sugar (in patients taking medication for diabetes), causing sweating or shakiness
  • dry cough
  • dizziness and light-headedness due to low blood pressure
  • decreased sexual drive or ability
  • tiredness and fatigue, especially in the early stages
  • mouth dryness in the early stages
  • nausea, vomiting, diarrhea (persistent in rare cases)
  • fainting
  • change in amount of urine
  • signs of infection (e.g., fever, chills, persistent sore throat)
  • yellowing of eyes or skin, dark urine
  • stomach or abdominal pain

Serious allergic reactions to this drug are unlikely, but immediate medical attention must be sought if they occur. Symptoms of a serious allergic reaction include but are not limited to:

  • rash
  • swelling of the face, mouth, tongue, or throat

In extreme cases, Ramipril may lead to potentially fatal liver problems. It is recommended to start treatment with the lowest dose.

Patients are started on the lowest dose and titrated up every 3 4 weeks as required.
Dosage comes in the following forms: 1.25 mg, 2.5 mg, 5 mg, 10 mg

Information Associated with Product:
Detail icon
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo


More Api at Taj Pharmaceuticals Ltd.

Quetiapine Fumarate

Quinine Sulfate

Rabeprazole Sodium


Ranitidine Hydrochloride


Rivastigmine Tartrate


Rosiglitazone Maleate


Tamsulosin HCl

Tegaserod Maleate

Terbinafine HCl

Tolterodine Tartrate









Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.